To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin

NCT01921946 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Fimasartan
DRUG: Rosuvastatin

Sponsor

Boryung Pharmaceutical Co., Ltd

Collaborators

[object Object]